Fuller Laboratories

Fuller Laboratories is a specialized diagnostics manufacturer located in Southern California, with particular expertise in vector-borne and zoonotic pathogens. For more than 30 years, the company has developed high-sensitivity immunoassays for the detection of infectious agents including Rickettsia, Ehrlichia, Anaplasma, Bartonella, Borrelia, Babesia, and other emerging pathogens. Its product portfolio spans IFA (immunofluorescence assay), MIF (micro-immunofluorescence), and ELISA formats, offered as both IVD kits and individual components. The company serves both clinical and veterinary markets. Its international clinical line provides IFA, MIF, and EIA diagnostic kits and components for human infectious-disease testing, distributed globally through a network of regional distributors. Its veterinary line supports animal health and zoonotic disease surveillance in companion animals, livestock, and wildlife. In the United States, Fuller Laboratories supplies clinical diagnostics as IVD kits and ASR (analyte-specific reagent) components. Fuller Laboratories maintains BSL-2+ and BSL-3 facilities for antigen production. Its antigens are purified from infected cell and erythrocyte cultures, with the exception of recombinant antigens. The company holds ISO 13485:2016 certification, an FDA Registration Number (3004036192), a Device Manufacturing License from the State of California, and an EC Declaration of Conformity. In 2018, it was granted a patent for In Vitro Propagation of Babesia microti (US 2018/0080004 A1). Beyond its catalog products, Fuller Laboratories offers custom, private label, and OEM products to the diagnostics industry. The company describes itself as customer-centric, working closely with testing laboratories and academic centers worldwide. Its stated goal is to produce optimal serological formats that differentiate true positives from true negatives for specific agents, with assays that are easily reproduced on a daily basis.

Fuller Laboratories is a specialized diagnostics manufacturer based in Southern California. According to the company, it has been working with vector-borne pathogens for over 31 years, focusing on Rickettsia, Ehrlichia, Anaplasma, and certain arboviruses, as well as maintaining a diverse collection of Babesia for in vitro antigen production. The company's long-standing expertise in these agents has positioned it as a supplier to reference laboratories and academic centers worldwide. A significant milestone came in 2018, when Fuller Laboratories was granted a patent describing In Vitro Propagation of Babesia microti (US 2018/0080004 A1). This patent reflects the company's research and development efforts in cultivating fastidious pathogens for diagnostic antigen production. Over the years, Fuller Laboratories has built a portfolio of IFA, MIF, and ELISA assays for both clinical and veterinary applications. Its antigens are produced in BSL-2+ and BSL-3 facilities, purified from infected cell and erythrocyte cultures, with the exception of recombinant antigens. The company holds ISO 13485:2016 certification, an FDA Registration Number (3004036192), a Device Manufacturing License from the State of California, and an EC Declaration of Conformity. Fuller Laboratories distributes its products globally through a network of regional distributors. It offers catalog products as well as custom, private label, and OEM products to the diagnostics industry. The company emphasizes a customer-centric approach, collaborating with testing laboratories and academic centers to serve regional healthcare systems. It continues to invest in R&D, with new products in development.

• 2018

  Granted a patent for In Vitro Propagation of Babesia microti (US 2018/0080004 A1).

Specialized manufacturer of high-sensitivity immunoassays for vector-borne and zoonotic infectious diseases, serving clinical and veterinary reference laboratories worldwide.

• Babesia microti IFA

  Sensitive IFA assay for detecting Babesia microti antibodies, supporting evaluation of tick-borne parasitic infections.

• Bartonella IFA Assay

  High-sensitivity IFA for detecting Bartonella henselae and B. quintana antibodies with clean, well-defined fluorescence patterns.

• Anaplasma & Ehrlichia Multi-Antigen Slides

  Purified antigen dots reduce background and improve clarity for differential diagnosis of tick-borne pathogens using the MIF format.

• SFG Rickettsia DFA

  Direct fluorescent antibody reagent for detecting spotted fever group Rickettsia in tissue and culture. Alexa Fluor 488 label with Evans Blue counterstain for crisp visualization.

• Spotted Fever Rickettsia IgG/IgM ELISA Kits

  ELISA kits for detection of IgG and IgM antibodies against spotted fever group Rickettsia.

• Rickettsia 12-well MIF Substrate Slide

  MIF substrate slide for Rickettsia testing.

• Orientia MIF IgG/IgM Kits

  MIF kits for detection of IgG and IgM antibodies against Orientia tsutsugamushi.

1. 1Home | Fuller Laboratoriesfullerlaboratories.com
2. 2About Us | Fuller Laboratoriesfullerlaboratories.com
3. 3Products | Fuller Laboratoriesfullerlaboratories.com
4. 4International Clinical | Fuller Laboratoriesfullerlaboratories.com
5. 5Fuller Laboratories (United States) - Wikidatawikidata.org